Sale – NeoV 980 nm Laser

NeoV 980 nm Laser

NeoV 980 nm Laser system family utilizes the highest quality and most advanced fiber technology for its various clinical indications. All fibers for EVLA and Proctology include a FUSED quartz cap for extra safety.

In addition, only the neoV platform enables access to the new CORONA Infinite Ring Fiber technology, the most advanced product on the global market for EVLA treatments, with patent pending cylindrical emission. Last, the laser platform supports a wider range of fiber core sizes and designs than other systems on the market, enabling work with fibers as thin as 270 microns

Technical Specifications:

Power output: 28 W,
Wavelength: 980 nm,
Pulse Width: 10 ms to 750 ms,
CW pulse,
Repeat Delay: 20 ms to 2 s,
SP pulse,
LCD touch screen,
Spot size: 0,5 mm, 1 mm, 2 mm, 3 mm,
Beam: Pcv 400 um,
Plug&Play,
Thermal protection,
Humidity protection,
USB,
Aiming Beam: 532 nm, 650 nm adjustable 1 Hz-6 Hz,
Menu Language: English, German, Spanish, Italian, French,
Power input: 19VDc, 4,7 A
Weight: 3,5 kg,
Dimensions: 22 x 22 x 10

Experience & Values

neoLaser was founded, developed and built by a group of seasoned and experienced individuals, focused on surgical laser technology, and having decades of relevant industry knowledge. The neoLaser team has been responsible for multiple successful surgical laser product launches in a variety of geographies and in multiple surgical disciplines.

Our core values include integrity, humility, intellectual curiosity and rigor, combined with a constant and aggressive strive for excellence in all we do. As a young and agile company, we understand the needs of our distributors, physicians and patients, react very quickly

Home Global Atlas sell NeoV 980 nm Laser with best quality product

The neoV platform, launched in 2013, has achieved phenomenal growth and acceptance on a global scale. Today, it is the tool of choice in over 1,000 hospitals, surgical centers, and clinics, in over 40 countries, having been used in over 200,000 medical interventions to date with a growth rate of 35-40% every year. It has become a true sign of excellence in technology, product design, and clinical results.